Samsung has announced a growth vision centered on improving the quality and safety of patient care through a commitment to lower radiation across its suite of medical imaging products. A prime example is Samsung’s GC85A premium fully digital X-ray system, which provides the same image quality with half the radiation. Samsung’s engine S-Vue™ 3.02 received FDA clearance last November for use at 50 percent dose reduction for adult chest exams. Constantly working to lower dose exposure is a top priority for radiologists and health care professionals, and the GC85A’s dose reduction represents a breakthrough in medical imaging technology.
When it comes to dose management, precision is key. The GC85A incorporates Samsung’s Image Post-processing Engine S-Vue 3.02 that provides spatially adaptive multi-scale processing and advanced de-noising technology delivering quality images with only half the dose.
“I recently participated in Samsung’s Low Dose Study and personally evaluated 10 chest X-rays, finding that the overall image quality was excellent,” said Dr. Hetal Patel, Chief of Radiology, ARMC-Moses Cone Health, Greensboro Radiology P.A. “The reduced-dose X-ray was either of comparable quality or better quality, and I would advocate for all chest X-rays to be done using this methodology.”
“In practice, patients who receive a chest X-ray from the GC85A are subjected to 8 microsieverts (μSv) of radiation. To place that in context, it is as low as the average dose exposed during a three-hour flight from Chicago to New York. In other words, the radiation levels of the Samsung GC85A are incredibly low and therefore safer for patients,” according to a press release.
Samsung’s efforts to educate and build awareness to dose radiation can be found at www.samsunghealthcare.com/en/lowdose.
*The dose reduction in GC85A digital chest radiography is based on limited phantom and clinical study results. Only routine PA chest radiography for average size adults were studied, excluding pediatric patients.